These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 36332835)

  • 1. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
    Wong PF; Dharmani M; Ramasamy TS
    Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fisetin Attenuates Cellular Senescence Accumulation During Culture Expansion of Human Adipose-Derived Stem Cells.
    Mullen M; Nelson AL; Goff A; Billings J; Kloser H; Huard C; Mitchell J; Hambright WS; Ravuri S; Huard J
    Stem Cells; 2023 Jul; 41(7):698-710. PubMed ID: 37279940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Skin aging-cellular senescence : What is the future?].
    Scharffetter-Kochanek K; Wang Y; Makrantonaki E; Crisan D; Wlaschek M; Geiger H; Maity P
    Dermatologie (Heidelb); 2023 Sep; 74(9):645-656. PubMed ID: 37638987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction.
    Nehlin JO
    Adv Protein Chem Struct Biol; 2023; 136():217-247. PubMed ID: 37437979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of resibufogenin, a component of toad venom, as a novel senolytic compound in vitro and for potential skin rejuvenation in male mice.
    Takaya K; Asou T; Kishi K
    Biogerontology; 2023 Dec; 24(6):889-900. PubMed ID: 37395866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomolecular Evaluation of Piceatannol's Effects in Counteracting the Senescence of Mesenchymal Stromal Cells: A New Candidate for Senotherapeutics?
    Alessio N; Squillaro T; Lettiero I; Galano G; De Rosa R; Peluso G; Galderisi U; Di Bernardo G
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Induction and Targeting of Senescent Mesenchymal Stromal Cells.
    Gresham RCH; Kumar D; Copp J; Lee MA; Leach JK
    Tissue Eng Part C Methods; 2022 Jun; 28(6):239-249. PubMed ID: 35438548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles from mesenchymal stromal cells: Therapeutic perspectives for targeting senescence in osteoarthritis.
    Boulestreau J; Maumus M; Jorgensen C; Noël D
    Adv Drug Deliv Rev; 2021 Aug; 175():113836. PubMed ID: 34166759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress-induced senescence in mesenchymal stem cells: Triggers, hallmarks, and current rejuvenation approaches.
    Lee SS; Vũ TT; Weiss AS; Yeo GC
    Eur J Cell Biol; 2023 Jun; 102(2):151331. PubMed ID: 37311287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Senescence and Senolytic Agents: Recent Updates on Their Role and Applications.
    Chandrakar L; Ambatwar R; Khatik GL
    Curr Top Med Chem; 2024; 24(2):157-178. PubMed ID: 38037999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.
    Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senotherapeutic Drugs: A New Avenue for Skincare?
    Lee BP; Harries LW
    Plast Reconstr Surg; 2021 Dec; 148(6S):21S-26S. PubMed ID: 34847094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.
    Suda M; Paul KH; Minamino T; Miller JD; Lerman A; Ellison-Hughes GM; Tchkonia T; Kirkland JL
    Cells; 2023 May; 12(9):. PubMed ID: 37174697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria-targeted senotherapeutic interventions.
    Atayik MC; Çakatay U
    Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejuvenation of Senescent Mesenchymal Stem Cells to Prevent Age-Related Changes in Synovial Joints.
    Sekelova T; Danisovic L; Cehakova M
    Cell Transplant; 2023; 32():9636897231200065. PubMed ID: 37766590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy.
    Liu H; Xu Q; Wufuer H; Li Z; Sun R; Jiang Z; Dou X; Fu Q; Campisi J; Sun Y
    Aging Cell; 2024 Jan; 23(1):e13921. PubMed ID: 37475161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.
    Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD
    Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.